Additionally, in contrast to reports from Western countries, we did not observe associations between an increased risk of malignancy and thiopurine or anti-TNF-α antibody usage among patients with IBD [16,22], but steroid usage appeared to be associated with the risk of tumor development. Here, TNF is linked to inflammatory bowel disease.